Primacyt

Primacyt GmbH, founded in 2006 and based in Schwerin, Germany, is a provider of advanced in vitro cell culture technologies and biological materials for the research and industrial communities. The company's product portfolio includes primary human and animal cells (notably hepatocytes), tissue fractions, skin models, and optimized culture media, complemented by contract research services for toxicology and ADME screening. It operates as a B2B supplier and service partner, emphasizing total quality commitment and worldwide support for biomedical research in toxicology, metabolism, and drug safety. Primacyt appears to be a private, revenue-generating company serving the preclinical research tools and services market.

Integrated platform of primary human and animal cells (hepatocytes, skin cells), tissue fractions, optimized culture media, and associated consumables for in vitro toxicology, ADME, and biomedical research.

Primacyt competes in the niche market for primary cells and specialized research tissues. Key competitors range from large corporations like Lonza, Thermo Fisher Scientific, and Charles River Laboratories to smaller specialty providers such as BioreclamationIVT (now part of Discovery Life Sciences) and Xenotech. Differentiation is achieved through product quality, technical expertise, and customer service.